NeuroSov: Understanding Parkinson’s Disease and the Urgent Need for Early and Effective Care

NeuroSoV is a biotechnology spin-off from the University of Beira Interior  focused  on developing disease-modifying therapies for Parkinson’s Disease and other  neurodegenerative disorders. Founded in 2020, the company builds on more than a decade of academic research and aims to translate scientific advances into clinically meaningful treatments. NeuroSoV’s innovation is supported by a strong intellectual property (IP) strategy, including a global patent portfolio, an exclusive licensing agreement with its academic partners.